We have utilized the favorable signal-to-noise ratios provid- The glutamate receptor antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX) reduced average unitary EPSP amplitudes; in contrast to the above manipulations, it had no effect on m,,, but significantly altered q,., which is consistent with its presumed postsynaptic mechanism of action. We conclude from these data that adenosine presynaptically reduces synaptic strength at Schaffer collateral-commissural synapses in the hippocampus by diminishing the number of quanta released, not by reducing the size of these individual quanta or postsynaptic sensitivity to excitatory neurotransmitter. These results suggest that the
to the variance of these responses (Af2/8), while quanta1 amplitudes (qo) were estimated by calculating the ratio of the response variance to average EPSP size (8/M). Estimates of m,, were highly correlated with those determined using the method of failures (m,). With paired stimulation (50 msec interpulse interval) there was a significant facilitation of the second unitary EPSP, accompanied by an increase in m,,, but not q,,, suggesting that this facilitation was of presynaptic origin. Superfusion of hippocampal slices with various concentrations of adenosine, the Al -selective adenosine receptor agonist cyclohexyladenosine, or the Ca2+ channel blocker cadmium significantly reduced average unitary EPSP amplitudes and at,,, without significantly altering qcv, suggesting a presynaptic locus for this inhibition. The 50% effective concentration for the apparent presynaptic action of adenosine on m,, in the present study (5.7 PM; 95% confidence limits = 4.2-7.7 PM) was significantly lower than its EC,, for reducing conventional, large EPSPs (33 AM; recorded with high-resistance microelectrodes), or extracellular field EPSPs (29 NM), as previously reported by this laboratory.
The glutamate receptor antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX) reduced average unitary EPSP amplitudes; in contrast to the above manipulations, it had no effect on m,,, but significantly altered q,., which is consistent with its presumed postsynaptic mechanism of action. We conclude from these data that adenosine presynaptically reduces synaptic strength at Schaffer collateral-commissural synapses in the hippocampus by diminishing the number of quanta released, not by reducing the size of these individual quanta or postsynaptic sensitivity to excitatory neurotransmitter. These results suggest that the Adenosine has been noted as a potent inhibitor of neuronal activity in the mammalian brain based upon a number of studies examining its effects on spontaneous neural firing rates (see Phillis and Wu, 1981 , for review) and evoked synaptic responses (Schubert and Mitzdorf, 1979; Dunwiddie and Hoffer, 1980; Okada and Kuroda, 1980) . While these actions of adenosine are well established, its source and distribution in the CNS are relatively unknown, although it seems to be tonically present and active under physiological conditions (Dunwiddie et al., 198 1; Zetterstrom et al., 1982; Fredholm et al., 1984; Haas and Greene, 1988) , and its extracellular concentrations can be elevated during periods of increased metabolic demand (ZetterStrom et al., 1982) . The depression of synaptic transmission has been noted as one of the distinguishing characteristics of adenosine both in the mammalian CNS (Dunwiddie, 1985) and at the neuromuscular junction (Ginsborg and Hirst, 1972) . It is at the neuromuscular junction that it has been possible to establish most conclusively, using quanta1 analysis of end-plate potentials at single nerve-muscle synapses, that adenosine reduces the average number of quanta of ACh released from the nerve terminal (i.e., quanta1 content, m), without affecting the size of these individual quanta (q) (Ginsborg and Hirst, 1972; Ribeiro and Walker, 1975; Silinsky, 1984) . In the CNS, the hypothesis that adenosine acts to diminish synaptic transmission via a presynaptic action has relied upon more indirect evidence since excitatory neurotransmitter release is typically evoked by the simultaneous activation of many presynaptic terminals, and since adenosine also acts to hyperpolarize CNS neurons (Greene and Haas, 1985; Jackson, 1985, 1987; Proctor and Dunwiddie, 1987) . Thus, the coexistence of both pre-and postsynaptic actions of adenosine has made it difficult to establish the relative contribution of each of these possibilities in regulating the overall degree of neuronal excitability. Several possible explanations exist to account for the inhibition of EPSPs activated through stimulation of excitatory afferents of CA1 pyramidal neurons in the hippocampus. Presynaptically, adenosine may decrease neurotransmitter release by reducing the number of vesicles released upon stimulation, by limiting the amount of excitatory transmitter in each vesicle, or by diminishing the number of activated synapses. Postsynaptically, adenosine could reduce neuronal sensitivity to the excitatory trans- Figure I . Measurement of unitary EPSPs and a comparison of noisecontaminated signal and noise variances (u") from a single CA1 pyramidal neuron using whole-cell recording. A shows the digital average of 100 EPSP responses (mean EPSP) and 100 samples of baseline noise (mean NOISE). Synaptic responses were evoked by two stimuli separated by 50 msec (S, and S,, as indicated in B). EPSP amplitudes were determined by calculating the difference between mean signal amplitude during a 3 msec period centered on the peak of each response (El and E2) and a baseline period immediately before the stimulus artifact (PI and P2). Noise amplitudes were determined by calculating the difference between periods NI and N2 on nonstimulus trials. B illustrates the variance of the averaged evoked response (SIGNAL + NOISE, vertical lines), shown in A, prior to subtraction of the noise variance (NOISE, horizontal line). Note that the variance associated with noise was much smaller than that associated with the evoked potentials.
mitter, decrease the excitatory conductance associated with glutamate receptors, or activate other ion channels that would shunt the EPSP recorded at the pyramidal neuron soma. Alternatively, some combination of these pre-and postsynaptic factors may account for the inhibition produced by adenosine. Statistical analysis of synaptic variability is one technique that has recently been used in the hippocampus to determine whether alterations in synaptic efficacy are derived from pre-or postsynaptic sources Malinow and Tsien, 1990; Foster and McNaughton, 1991) . These statistical techniques together with the use of the low-noise whole-cell recording configuration to record "unitary" EPSPs ) from hippocampal CA1 pyramidal neurons have permitted us to evaluate the presynaptic versus postsynaptic actions of a variety of pharmacological manipulations. By comparing two measures of synaptic efficacy, one sensitive only to presynaptic changes in neurotransmitter release and the other sensitive to presynaptic and postsynaptic changes, we have found that adenosine acts predominantly at the excitatory amino acid nerve terminal to reduce synaptic transmission.
A portion of these results have appeared in preliminary form (Dunwiddie et al., 199 1) .
Materials and Methods
Hippocampal slice preparation. Experiments were performed using transverse hippocampal slices of 400 lrn thickness, obtained from male Sprague-Dawley rats; weighing between 120 and 160 gm (Sasco, Omaha, NE). Slices were cut in nreaassed. 4°C artificial cerebrosuinal fluid (aCSFl. using either a vibrating ti&ue slicer (Technical Products International; St. Louis, MO) or a Sorvall tissue chopper (Newtown, CT), as described previously (Lupica et al., 1990) . These slices were then transferred to a beaker containing aCSF, which was constantly aerated with a 95% O,, 5% CO, mixture at 32°C and left undisturbed for at least 1 hr prior to whole-cell recording. The aCSF consisted of (in mM) NaCl, 126; KCl, 3.0; MgCl, , 1.5; CaCl, , 2.4; NaH, PO, , 1.2; NaHCO, , 26; 11; at pH 7.4 . When testing procedures were begun, slices were placed in a recording chamber (-0.5 ml volume) and submerged with a constant flow of oxygenated (95% O,, 5% CO,), preheated aCSF (33 * 1°C) at a flow rate of 2 ml/min. Electroph$siological recording. Intracellular recordings of membrane potentials were obtained using a bridge circuit electrometer (Axoclamp-2A, Axon Instruments, Burlingame, CA). Membrane potentials, not membrane currents, were measured due to the superior signal-to-noise ratio this method provides over the whole-cell voltage clamp, and because it is unlikely that responses to individual quanta interact in a nonlinear fashion. Whole-cell electrodes were pulled in three stages from borosilicate (Omega-dot) capillary tubing (i.d., 1.12 mm; o.d., 1.5 mm; Glass Company of America, Bargaintown, NJ) using a Flaming/Brown micropipette puller (P-87; Sutter Instrument Co., Novato, CA). These electrodes had resistances of 4-6 MB when filled with the following solution (in mM): CaCl,, 0.5; MgCl,, 2.0; KCl, potassium gluconate, 135.0: EGTA. 1.0: HEPES. 10.0: ATP. 2.0: at uH 7.2-7.4.
Pyramidal neurons were located in the slice by monitoring the voltage change in response to a -0.1 nA, 20-msec-duration, square-wave current pulse passed through the whole-cell electrode. As this electrode was advanced through the stratum pyramidale in area CAl, an increase in resistance (observed as an increase in voltage) was seen when a cell was encountered. Negative pressure was then applied to the patch pipette, and a seal formed between the electrode tip and the cell membrane. When the membrane patch resistance reached z 1 GB, the membrane was ruptured by further application of negative pressure, and recordings commenced in the whole-cell configuration. Whole-cell membrane input resistance was determined by monitoring the membrane response to current pulses immediately following rupture of the membrane patch.
Synaptic stimulation was delivered using a bipolar, twisted tungsten wire electrode (monophasic, 0.1 msec pulses of 2-5 V), placed on the stratum radiatum layer of the slice within approximately 1.5-2.0 mm of the recording electrode. Unitary EPSPs were evoked using paired stimuli of the same intensitv. seoarated bv 50 msec (EPSP, and EPSP,) . at a rate ofO.167 Hz. Stimulus intensity was set to elicit EPSP, responses that could be readily distinguished from baseline noise on SO-95% of the trials. All electrophysiological signals were digitized at 7 kHz and stored on a hard disk drive residing in an AT-type personal computer, using a computer program developed in this laboratory (NEUROPRO; R.C. Electronics, Goleta, CA). Resting membrane potential was continually monitored using a chart recorder (Gould Electronics, Cleveland, OH).
To reduce the influence of GABA-mediated inhibitory postsynaptic ootentials (IPSPs) on unitarv EPSPs. the GABA, recentor antaaonist bicuculline' methiodide ( 10 ;M; Sigma, St. Louis;' MO j was present in the aCSF throughout each experiment. Also, to reduce the degree of spontaneous synaptic activity in the CA1 pyramidal neurons, and to prevent drug effects mediated by receptors located on CA3 neurons from altering axonal excitability, the CA3 region of each hippocampal slice was removed using a scalpel blade.
Data collection. Figure IA illustrates the procedures for measuring unitary EPSP and noise amplitudes. Peak EPSP amplitudes were measured by calculating the difference between average signal amplitude during a 3 msec period (approximately 2 1 digitized points) centered on the peak of each response (El and E2) and a 3 msec baseline period immediately prior to the stimulus artifacts (Pl and P2). The amplitude of the background recording noise was determined by calculating the difference between 3 msec periods corresponding to the Pl and El periods on nonstimulus trials (Nl and N2). Nonstimulus trials were alternated with stimulus trials. Determination of peak EPSP locations were obtained by averaging -100 consecutive responses and centering the 3 msec measurement period upon the largest value of the response. Each sweep was then reanalyzed using these settings. Between 150 and 275 response and noise traces were collected for each recording epoch (control, drug, and washout periods) and used in the subsequent statistical analyses. In addition, since the statistical estimations of synaptic efficacy relied upon favorable signal-to-noise ratios, we established a criterion that during the control epoch the contribution to the total variance (i.e., the noise-contaminated signal variance) made by the background recording noise must be ~30%. Cells not meeting this criterion were not included in this study.
Drugs. Adenosine and cadmium chloride were purchased from Sigma (St. Louis, MO). 6,7-dinitroquinoxaline-2,3-dione (DNQX) was pur-chased from Tocris Neuramin (Essex, UK). The Al adenosine agonist cyclohexyladenosine (CHA) was purchased from Calbiochem (La Jolla, CA).
Results
The average resting membrane potentials ( f 1 SEM) of 57 CA 1 pyramidal neurons in which stable whole-cell recordings were obtained for at least 20 min was -65.5 + 0.6 mV, while the average membrane input resistance of46 ofthese cells was 117.4 f 3.9 MQ. This resting membrane potential is slightly higher than that recorded from the same cell type using conventional high-resistance microelectrodes (-62.6 * 1.0 mV; y1 = 28); the input resistance is much higher than that recorded with highresistance microelectrodes in our laboratory (29.7 f 3.1 MQ; n = 12). Since the number of responses necessary for accurate estimation of synaptic variability within each epoch was large (Martin, 1966; Hubbard et al., 1969) , it was necessary to record stable average EPSP amplitudes, in some instances, for periods up to 2 hr. Additionally, we required that < 30% of total variance of the unitary EPSPs be derived from background noise. Twenty-eight of the 57 pyramidal cells met both of these criteria and were included in the statistical estimates of the quanta1 parameters.
Response variability. A unique feature of the unitary EPSPs was that, despite relatively stable average EPSP amplitudes during any single recording epoch, they showed a high degree of variability from trial to trial. This variability is illustrated in Figure lB , where the total variance of 100 responses in a single cell (i.e., noise-contaminated signal variance) is plotted on the same scale as the noise variance. Another index ofthe variability of these responses is the coefficient of variation (CV = SD/ mean). We examined the CV for unitary EPSPs (mean amplitude of 0.59 + 0.03 mV; n = 16 cells) and found that they had an average CV of 0.621 (range, 0.440-0.961). These CV values compare favorably with those observed at single synapses in pyramidal cell culture and in hippocampal slices . In comparison to these unitary EPSPs, a sample of extracellular field EPSPs in CA1 had a mean amplitude of 0.74 * 0.03 mV and an average CV of 0.050 (range, 0.025-0.082; n = 10 slices). Large intracellular EPSPs recorded from CA1 pyramidal neurons with whole-cell electrodes (mean EPSP amplitude = 13.53 + 1.43 mV) had an average CV of 0.063 (CV range, 0.048-0.096; n = 8 cells). This significant lO-12-fold higher variability in unitary EPSP responses, as compared to field EPSPs or "macroscopic" intracellular EPSPs (p < 0.000 1, ANOVA), might arise from noise in the recording system (e.g., variations in the quality of the pipette-membrane seal) or shortterm fluctuations in the efficacy of synaptic transmission. However, this variability cannot be attributed entirely to recording factors, because, as Figure 1 illustrates for a single cell, the unitary EPSP response variance was found to be much higher than the background recording noise variance. Overall, from a total of 12 pyramidal neurons, the noise variance contributed only 10.9 f 1.7% to the total variance of EPSP,. Therefore, approximately 90% of the unitary EPSP variability appears to be of biological origin, and there are a variety of ways in which this might arise. Some of these are (1) variation in the number of quanta released upon stimulation, (2) axonal conduction failknowledge, have not been described. Also, responses to locally applied glutamate do not typically show this type of variability (Proctor and Dunwiddie, 1987; Hvalby, 1990) . The first three possibilities are obviously presynaptic in origin, and the majority of our experiments were designed to test the hypothesis that one of these presynaptic mechanisms was the target of synaptic modulators. If the variability we observed in unitary EPSPs arises from presynaptic factors, then agents that change the variability must be working through presynaptic mechanisms.
Statistical analysis. In order to characterize the variability of these responses more formally, one must have a measure of this intrinsic variability that is independent of the absolute response amplitude, such as the CV. However, a more useful measure of synaptic responses is 1/CV2, which we refer to as mC.,. This parameter can also be calculated as mcv = Mv(u; -u',) = M2/a2, where M is the mean EPSP amplitude, a$ is equal to the noisecontaminated EPSP variance, and u', is the background noise variance. This is a measure of synaptic variability that is insensitive to changes in postsynaptic sensitivity (e.g., if a receptor antagonist reduced every response by 50%, this parameter would be unchanged), but would be sensitive to the presynaptic factors responsible for EPSP variability (Martin, 1966; Hubbard et al., 1969; Malinow and Tsien, 1990; Foster and McNaughton, 199 1) . It should be stressed that this parameter (m,,) is a unitless index of variability that makes no assumptions as to the source of the variance. However, if the source of the variability is in the number of quanta released, and ifthe number of quanta released follows a binomial distribution, then it can be shown that mcv = M2/u2 = Npl(1 -p), where p is the probability of the release of a quantum of transmitter and N is the number of quanta available for release. If release probability is very small (p << 1 .O), then this parameter reduces to mcv = M2/u2 = Np/(l -p) =Np=m (mean quanta1 content).
While the parameter mCV is useful because it requires few assumptions as to the sources of synaptic variability, it is complicated by the fact that it is subject to errors of measurement when sample sizes are small or when signal-to-noise ratios are not favorable (Martin, 1966) . Additionally, this parameter assumes that the responses to individual quanta at all activated release sites are of uniform size (Kom and Faber, 199 1) .
Another parameter can be calculated using this response variability:
where v is the vesicular content and z is the postsynaptic sensitivity to the transmitter. Again, if release probability is very small (p < l.O), then this parameter will reduce to q,, = uVM = ( 1 -p)vz x vz = q (quanta1 size).
ure, (3) variation in the size of individual quanta, (4) variation It should be noted that the estimator of mean quanta1 content in postsynaptic sensitivity, and so on. The last possibility, al-(mJ is sensitive to changes in N and p, which are both presynthough plausible, seems unlikely because mechanisms that could aptic parameters, but will not be affected by changes in v (veproduce such rapid changes in postsynaptic sensitivity, to our sicular content), which is also a presynaptic parameter, or by Another approach that has been used to determine mean quanta1 content at synapses where the postsynaptic response to presynaptic stimulation is sometimes absent, is the method of failures, originally described by de1 Castillo and Katz (1954a,b) , according to the equation
where N is total number of stimulation trials within an epoch and n, is the total number of failures within the same epoch (Martin, 1966) . Figure 2 illustrates that the separation between the noise amplitude distribution and the noise-contaminated response distribution was sufficient to permit us to distinguish synaptic failures from background recording noise under most conditions. Also, since the noise amplitudes were normally distributed (Fig. 2) , the total number of failures was determined by doubling the number of responses that were less than zero and adding those equal to zero (Sayer et al., 1989 Foster and McNaughton, 199 1) . In the case of the neuromuscularjunction, m,corresponds quite closely to m,, and appears to be an accurate estimator of mean quanta1 content. With unitary responses in hippocampus the interpretation of m, is less clear. However, if the occurrence of failures is related to some presynaptic event (e.g., axonal conduction failure, failure of the nerve terminal to release transmitter, etc.), then experimental manipulations that change m, must be affecting the presynaptic side of the synapse.
Eficts of synaptic facilitation on m,, and q,,. The preceding analysis suggested that mCV is a parameter that should be altered by agents that modify synaptic transmission at a presynaptic site, whereas effects on qCV should reflect changes in pre-and/or postsynaptic sensitivity. In our initial experiments, we examined these hypotheses using treatments whose sites of action are relatively well understood.
One form of short-term synaptic plasticity that has been suggested to be of presynaptic origin is that of paired-pulse facilitation (de1 Castillo and Katz, 1954a; Creager et al., 1980; Hess et al., 1487; Foster and McNaughton, 1991) . In the present study, paired stimulation of afferents to CA1 resulted in the facilitation of EPSP, in every cell tested (n = 27; examples from single cells, Figs. 1, 30, 40, 5D) , with an average increase in EPSP, to 158 f 12% of EPSP, (n = 27 cells; p < 0.0001, ANOVA). This facilitation was also accompanied by a significant average increase in mCV to 177 -t 18% of control (p < 0.000 1, ANOVA), while q,, calculated for EPSP, remained unaltered by the preceding stimulation (100 f 12% of EPSP,).
Effects ofDNQXon m,, and q,,. DNQX is a glutamate receptor antagonist that should reduce the size of unitary EPSPs by an action at a postsynaptic site. Thus, we would predict that DNQX should reduce q,, and have no effect upon m,,. As Figure 3 illustrates for a single pyramidal neuron, DNQX (1 PM) reduced the average amplitude of EPSP, to approximately one-half its previous amplitude, without altering mCV (Fig. 3B) . DNQX did, however, cause a marked decrease in &,, reducing this parameter more than threefold (Fig. 3C' ). For all cells tested (n = 5), DNQX reduced the average EPSP, response to 32 -t 2% of control, and that of EPSP, to 29 f 4% of control. The average reductions in q,, for EPSP, and EPSP, to 25 f 4% of control and 30 f 9% of control, respectively, were statistically significant (p < 0.000 1, ANOVA), but DNQX had no significant effect on m,, (112 f 35% of control and 90 f 29% of control, EPSP, and EPSP,, respectively). These results suggest that DNQX acts to reduce mean EPSP amplitude by decreasing the quantity, v (vesicular neurotransmitter content), or, more likely, by changing the postsynaptic sensitivity to glutamate (z) (Andreasen et al., 1988 (Andreasen et al., , 1989 Herreras et al., 1989) .
Effects of cadmium on mcv and q,,. In order to determine the effect on m,, and q,, of decreasing average EPSP amplitudes via a presumed presynaptic mechanism, we examined the actions of the Ca2+ channel blocker cadmium (Hille, 1992) . Figure 40 shows a single CA 1 pyramidal neuron in which cadmium (10 FM) reduced the average amplitude of EPSP, and EPSP,. Unlike DNQX, however, cadmium reduced mcv without altering q,, (Fig. 4AJ) . Figure 4C illustrates the relationship between m,, and average EPSP, amplitude (n/r) in this same neuron, and shows that A4 and mCV change in parallel. In five pyramidal neurons tested with cadmium, EPSP, and EPSP, amplitudes were reduced to 46 + 7% of control and 58 + 10% of control, respectively, while mCV was reduced to 47 f 12% of control and 56& 10% of control. There was no significant change in q,, for these same cells (94 ? 12% of control and 105 Ifr 16 % of control, EPSP, and EPSP,, respectively). It can also be seen in Figure  4C that the decrease in average EPSP amplitude (M) caused by cadmium can be explained quantitatively by a decrease in mCV.
Eficts of adenosine on m,, and q,,. Like cadmium, the primary effect of adenosine was to reduce m,, without affecting 4,". The effects of adenosine (5 PM) on a single CA1 pyramidal neuron can be seen in Figure 5 . The mean unitary EPSP was reduced by adenosine, and this effect was rapidly reversed by washing with control aCSF (Fig. 5A) . It can also be seen that adenosine reduced the presynaptic parameter mCV (Fig. 5B) Recovery from the effect of DNQX was not examined due to the extremely slow washout of this drug. DNQX reduced the average amplitude of the EPSPs, and reduced the variability of the responses as well. B, Time course of the effect of DNQX on mean quanta1 content (m,,) calculated for successive groups of 20 responses using the techniques described in Materials and Methods. Note the lack of effect of DNQX upon this parameter and the high degree of variability of m,,, which is a consequence of the relatively small sample size used to estimate this parameter (Hubbard et al., 1969) . C, Time course of the effect of DNQX on quanta1 amplitude (4,") calculated over the same periods as in B. As can be seen, the effect of DNQX was to reduce q,,, which could reflect either a change in vesicular neurotransmitter content or a change in postsynaptic sensitivity. The latter effect would be consistent with the known ability of DNQX to block postsynaptic receptors. D, Thirty consecutive unitary EPSP responses, representing those from which the data in A-C are derived, are shown prior to and during DNQX application. Note the marked reduction in the amplitude of the EPSP responses during DNQX application. In this figure and in Figures 4 and 5 , the arrows mark the times of synaptic stimulation. effect upon the parameter q,, in this cell (Fig. 5C ). The overall effect of 5 PM adenosine on five cells was to reduce the average amplitude of EPSP, to 40 + 7% of control and the average mcv to 42 -t 10% of control, while the average EPSP, amplitude was reduced to 44 f 9% of control, and average m,, for EPSP,, to 30 f 7% of control. Figure 6 shows that the effect of adenosine upon m,, was concentration dependent, with an EC,, for the reduction in m,, of 5.7 PM (95% confidence limits = 4.2-7.7 FM). This EC,, value is significantly lower than EC,, values reported by this laboratory for the inhibition of CA1 field EPSPs (29 PM) or large intracellular EPSPs, recorded with conventional high-resistance microelectrodes (33 PM) (Dunwiddie and Hoffer, 1980; Proctor and Dunwiddie, 1987) . At no concentration did adenosine significantly affect 4,". Significant effects of adenosine on resting membrane potential were not observed at any concentration (102 * 3% of control).
Previous studies have shown that both A 1 and A2 adenosine receptors exist in the hippocampus, and that the pre-and postsynaptic electrophysiological effects of adenosine appear to be mediated by Al receptors (Dunwiddie and Fredholm, 1989; Lupica et al., 1990) . However, adenosine is not a particularly selective agonist for A 1 or A2 adenosine receptors. Furthermore, it was possible that the actions of adenosine upon the presynaptic measure mcv were due to intracellular receptor-mediated, or non-receptor-mediated metabolic effects of this purine. Thus, in an effort to better characterize the mechanisms underlying the reductions in mcv, we utilized the adenosine agonist CHA (5 nM), which is highly selective for Al receptors and a poor A . of 40 responses, as described in Materials and Methods. B, Cadmium effects on qcv also calculated for groups of 40 responses. C illustrates the relationship between the average EPSP, amplitude (M) and the parameter m,, before (control), during (Cd>+), and following (wash) superfusion of the hippocampal slice with cadmium. The high degree of correspondence between these two measures, using least-squares linear regression (r* = 0.93; slope = 7.60; p < O.OOOl), indicates that the effect of cadmium on mcV is sufficient to account quantitatively for over 90% of the observed change in M. D, Thirty consecutive unitary EPSP responses before (CONTROL) and during superfusion with cadmium chloride. substrate for adenosine transmembrane transport systems (Williams and Cusack, 1990 ). CHA caused a qualitatively similar reduction in the average amplitude of unitary EPSPs (n = 5 cells), reducing these responses to 50 -t 12% of control (EPSP,) and 54 f 11% of control (EPSP,). In a manner that was also similar to adenosine, CHA reduced the parameter mcv to 58 * 22% of control (EPSP,) and 52 L 16% of control (EPSP,). CHA, similar to adenosine, did not significantly alter q,, (98 f 17% of control and 116 + 35 % of control, EPSP, and EPSP,, respectively).
Group summaries of all of the above manipulations can be seen in Figure 7 , where the relative change in average EPSP size (M) is plotted against the relative change in mcv. One would predict that if m,, were indeed related to the amount of neurotransmitter released, then Mand mcu should change in parallel and, when plotted, these points should fall along a line possessing a slope of unity. However, if a manipulation decreased average EPSP amplitudes via a postsynaptic mechanism leaving mc, unaltered, then these points should fall along a horizontal line (i.e., possessing a slope of zero). As Figure 7 illustrates, paired-pulse facilitation, cadmium, adenosine, and CHA treatments all caused a parallel shift in m,, and M. A least-squares fit to these points (not shown) yielded a regression coefficient of r2 = 0.98 and a slope of 1.06, indicating that the alterations in mcv were sufficient to account for the changes observed in average EPSP amplitude for these manipulations. This figure also shows that, for DNQX, the significant reduction in average EPSP amplitude occurred independently of significant changes in mcv. The effects of all of manipulations on mcv and q,, for EPSP, and EPSP, are summarized in Figure 8 , where it can be seen that the only manipulation to reduce q,, (Fig. 8B) significantly and to have no significant effect on m,, was DNQX (Fig.  8A) . Furthermore, this figure shows that the magnitude of facilitation of m,, for EPSP, was not significantly altered by any of the pharmacological manipulations.
Comparison of m,, with m, As discussed above, one of the possible interpretations of m,, is that it estimates the mean quanta1 content (m) at these synapses. Another way to estimate (de1 Castillo and Katz, 1954a,b; Martin, 1966; Hubbard et al., 1969) . Figure 9 illustrates the relationship between mCV and m, for all cells that demonstrated at least two failures during the control and drug application period (calculated from EPSP, only; EPSP, showed so few failures that this approach could not be used). In general, the correlation between values obtained using m,, and m, was high (9 = 0.83; slope = 1.2; p < 0.0001; solid line, Fig. 9 ). The greatest correspondence between mCV and m, was obtained when these values were less than -2, while the largest consistent deviations from a slope of unity (broken line, Fig. 9 ) were seen when these values were larger than -2, or in the presence of DNQX (mean m,, = 4.1 -t 1.3; mean m,= 1.7 f 0.3). Generally, t of extracellular field EPSPs (vertical line labeled&@ was significantly greater than for unitary EPSPs (Dunwiddie and Hoffer, 1980) . The EC,, derived from experiments with large EPSPs recorded with conventional intracellular electrodes (33 PM) was also larger than the EC,, for unitary EPSPs (Proctor and Dunwiddie, 1987) . In this and all subsequent figures, error bars represent 1 SEM. Comparison of estimates of quanta1 content calculated using m,, and the method of failures (m,) during control periods and during the indicated pharmacological manipulations. ADO, adenosine; DNQX, 1 PM DNQX; Cd2+, 10 PM cadmium chloride; CHA, 5 nM CHA. The correlation between m,, and m, was high (9 = 0.83; slope = 1.2; solid line); however, there was a tendency for points to fall above a line with a slope of unity (broken Une) when m was large. Note that DNQX caused a reduction in m, which probably resulted from a reduction of the parameter q,, to a level that was difficult to distinguish from background recording noise, and hence resulted in a greater number of observed failures.
recording configuration, can be useful in the determination of the site of action of drugs that modify synaptic transmission. This technique has also been useful in the evaluation of the loci of changes induced by physiological manipulations known to cause long-term alterations in synaptic plasticity Malinow and Tsien, 1990; Foster and McNaughton, 1991; Renner et al., 1991) although there still remains considerable controversy concerning these results (Kom and Faber, 1991) . Since only a small portion of the variability in our recordings of unitary EPSPs could be ascribed to the background recording noise, it is reasonable to assume that the mathe pharmacological manipulations that reduced m,, also reduced mf to the same degree.
Discussion
The results of the present investigation suggest that the technique of statistical analysis of synaptic variability, together with the enhanced signal-to-noise ratio provided by the whole-cell A . B . DNQX was the only agent to reduce q,, (from approximately 200 to 50 pV), but had no effect on m,,. ** , p < 0.00 1 compared to control (ANOVA).
jority of this variance was due to biological factors. The question, with regard to the usefulness of the statistical measures employed in the present investigation, then becomes, what is the source of this high degree of response variability? First, among the many possible presynaptic factors that may account for the high degree of unitary EPSP variability is that the extracellular electrical stimulation used to elicit EPSPs actually activated a varying number of presynaptic axons. This would result in a situation where mcv and m, might actually represent the average number of nerve terminals activated by the stimulation, and not the average number of quanta released by a given presynaptic stimulus. This would imply that the reductions in m,, and m, seen with cadmium, adenosine, and CHA were due to an alteration in axonal excitability and not mean quanta1 content. We have examined this possibility, specifically, with reference to adenosine, using extracellular recording of presynaptic fiber spikes in the absence of postsynaptic glutamate responses (high concentrations of DNQX and the NMDA antagonist D,L-2-amino-5-phosphonovalerate in the medium were used to block synaptic responses). We have found that while adenosine does significantly reduce these presynaptic fiber potentials, this effect is blocked by removing the CA3 area of the slice (K. Miller and T. V. Dunwiddie, unpublished observations) . This suggests that adenosine reduces the presynaptic fiber spike (and axonal excitability) via hyperpolarization of CA3 pyramidal neuron somata and Schaffer collaterals by activating adenosine receptors located only on CA3 pyramidal neuron somata. Since, in the present study, we removed the CA3 region of our slices prior to unitary EPSP recordings, it is unlikely that differences in axonal excitability can account for the reductions in mcv and m, seen with adenosine or CHA. It is also unlikely that cadmium, at the concentration used in this study (10 PM), reduced m,, and m, by altering axonal excitability, since its best-documented action is to block voltagesensitive Ca*+ channels (Fox et al., 1987; Hille, 1992) . Furthermore, it is more plausible that an increase in m accounts for the enhancement of EPSPs with paired pulses of equal magnitude, rather than a greater number of stimulated axons upon the second stimulus.
A second possible source of the EPSP variability might be a wide range in the amplitudes of individual quanta (q). If this were the case, then any changes in mcv and m, might be due to alterations in the size and variance of quanta1 amplitudes. The possibility that quanta1 amplitude may be variable at Schaffer collateral-commissural synapses has been addressed by a few investigators. Larkman et al. (1991) found that peaks (fitted using the maximum likelihood estimator) seen in amplitude histograms of -1000 unitary EPSPs were equally spaced and had similar SD values. Similarly, Edwards et al. (1990) studying inhibitory synaptic inputs to dentate granule cells, have suggested that quanta1 amplitudes are stationary at these synapses. However, this group has proposed that the uniformity of quanta1 amplitudes is determined not presynaptically by invariant vesicle size, but postsynaptically by a fixed number of receptors that are saturated by the contents of a single synaptic vesicle (Edwards et al., 1990; Edwards, 199 1) . Clearly, this latter hypothesis challenges the validity of using quanta1 release statistics based upon simple binomial models. However, the results of both Larkman et al. (1991) and Edwards et al. (1990) suggest that quanta1 amplitudes are invariant at these synapses, and that quanta1 variability cannot account for the high degree of variance of unitary EPSPs at Schaffer collateral<ommissural synapses. In contrast to these studies demonstrating uniform quantal amplitudes, a study conducted using synaptically connected pyramidal neurons in culture demonstrated that the high degree of EPSP variability could be explained by the variance in quanta1 size, possibly due to a wide range of presynaptic vesicle sizes . Thus, it is difficult to draw conclusions from these studies as to the uniformity of quanta1 size in the CNS, and our own data do not provide sufficient information to resolve this issue, particularly without accurate measurement of spontaneous miniature EPSPs observed at the same synapse(s). Furthermore, histograms describing our data do not generally show clearly differentiated peaks corresponding to the release of one, two, three quanta, and so on (see Fig. 2 ), though our sample sizes were not large compared to those of Larkman et al. (199 l) , for example. Nevertheless, if the source of variability was variation in quanta1 amplitude, our results would suggest that adenosine, cadmium, and the initial response of a closely spaced pair of responses (i.e., paired pulses) are all capable of changing the size of individual quanta, and this seems unlikely.
A third possibility is that one of a variety of postsynaptic alterations could govern the high degree of variability seen in unitary EPSP responses. A few of these are trial to trial alterations in the number of functional postsynaptic receptors, large fluctuations in the probabilities of channel openings, alterations in neurotransmitter uptake and degradation systems, brief local changes in resting membrane potential, or variations in voltageactivated conductances that may shunt EPSPs (Kom and Faber, 1991) . However, since responses to locally applied glutamate, albeit larger than those reported here, typically do not show this type of variability (Proctor and Dunwiddie, 1987; Hvalby, 1990) , and since ultrastructural and biochemical data have not been presented to support one or more of these alternatives, they must be treated as tenable though unlikely hypotheses.
A final possibility is that the high degree of EPSP variance results from trial to trial variability in the number of quanta released (m). Support for this hypothesis is derived from the close agreement between the present findings and the predicted results for a number of experimental manipulations that should change m and q in well-established ways. Thus, the predictions that the conditioning pulse of a pair will cause facilitation of the second response that can be explained by an increase in m (Hess et al., 1987; Foster and McNaughton, 1991) and the decrease in m caused by limiting Ca2+ availability to nerve terminals comes from the original description of these phenomena by de1 Castillo and Katz (1954a,b) at the neuromuscular junction. Similarly, the prediction that DNQX should reduce qcv but not m,, was also supported by our data. In this context, the observation that adenosine reduced mcv but not qcv is quite consistent with the effects that have been described for adenosine in numerous studies at the neuromuscular junction (Ginsborg and Hirst, 1972; Ribeiro and Walker, 1975; Silinsky, 1984; Ribeiro and Sebastiao, 1985) . Thus, the present results describe changes in our estimated parameters that, in every case, are consistent with those seen in a variety of preparations. Additionally, our estimate of qcv determined at Schaffer collateralcommissural synapses agrees quantitatively with previous studies that utilized a variety of techniques to estimate this parameter in the CNS (McNaughton et al., 1981; Yamamoto, 1982; Hess et al., 1987; Sayer et al., 1989 Sayer et al., , 1990 Friedlander et al., 1990 ; Foster and McNaughton, 199 1; Yamamoto et al., 199 1).
The evidence provided by these experiments demonstrates that the primary action ofadenosine in the hippocampus is to act upon presynaptic receptors to limit excitatory neurotransmitter release. This is supported by the observation that adenosine concentration-dependently reduced average unitary EPSP amplitudes and m,, values in parallel, without significantly affecting q,, or resting membrane potential. Furthermore, the similarity between CHA and adenosine on these parameters suggests that the reduction of synaptic transmission by adenosine occurred through the activation of presynaptic Al receptors. These results are consistent with previous reports using lessdirect measures of neurotransmitter release in the CNS (Michaelis et al., 1979; Dunwiddie and Hoffer, 1980; Jonzon and Fredholm, 1984; Feuerstein et al., 1985; Jackisch et al., 1985; Burke and Nadler, 1988; Haas and Greene, 1988; Dunwiddie and Fredholm, 1989; Lupica et al., 1990) and with studies of the effects of adenosine upon quanta1 neurotransmitter release at the neuromuscular junction (Ginsborg and Hirst, 1972; Ribeiro and Walker, 1975; Silinsky, 1984) . Thus, the reduction in quanta1 content(m) at nerve-muscle synapses without alteration of the average size of a quantum of neurotransmitter (q) is consistent with its reduction in m,, and the absence of its effects on q,, in the present study. The lack of effects of adenosine on q,, and the prominent reduction of m,, were mimicked by the Ca2+ channel blocker cadmium, providing further support for the presynaptic locus of adenosine's actions. Furthermore, the effects of elevating Ca2+ or lowering Mgz+ concentrations on m,, have been described previously, and these manipulations are consistent with an enhancement of presynaptic function (Malinow and Tsien, 1990) . The results of the present study are also in agreement with those of Scholz and Miller (199 l) , who demonstrated that the inhibitory effects of adenosine on monosynaptic EPSPs in cell culture were primarily presynaptic, and mediated by an Al receptor. An unexpected finding of this investigation was that the 50% effective concentration of adenosine for the inhibition of m,, (-6 PM) was approximately fivefold lower than EC,, values for adenosine's reduction of larger EPSPs, recorded with conventional high-resistance microelectrodes, and extracellular field EPSPs, both elicited by activation of Schaffer collateral<om-missural inputs to CA1 pyramidal neurons (Dunwiddie and Hoffer, 1980; Proctor and Dunwiddie, 1987) . The reduced potency of adenosine with larger EPSPs may be explained by the phenomenon of nonlinear summation of quanta at these synapses. Thus, the reduction of EPSP amplitude by adenosine would be diminished with increasingly larger EPSPs, since the contribution of each quantum to this response becomes less with further depolarization of the postsynaptic membrane (Martin, 1966) . This possibility was specifically investigated using extracellular measurements of EPSPs in hippocampus, where it was found that adenosine inhibited small field EPSPs to a greater degree than larger responses (Dunwiddie, 1984) . Other possibilities are that the low-intensity unitary EPSP stimulation selectively activates a subpopulation of nerve terminals that are more sensitive to adenosine, or that a novel adenosine receptor is present on low-threshold fibers. Regardless of which possibility is correct, the EC,, of adenosine for the inhibition of mcv in the present study is quite close to the estimated concentration of endogenous adenosine distributed in the extracellular space in the hippocampus (i.e., l-2 wM) (Zetterstrom et al., 1982; Fredholm et al., 1984) and supports the suggestion that adenosine exerts a tonic inhibition of normal synaptic transmission in CA1 (Dunwiddie et al., 198 1; Haas and Greene, 1988) .
There are at least two possible explanations for the absence of significant postsynaptic actions of adenosine on resting membrane potential (and, indirectly, upon q,,) in the present study. First, the concentration at which adenosine was 50% effective at reducing mcv (-6 PM) is approximately fivefold lower than its EC,, at postsynaptic adenosine receptors (Dunwiddie and Fredholm, '1989) . Second, during whole-cell recording in the absence of GTP in the patch pipette, the activation of the G-protein-linked potassium conductance that mediates the postsynaptic hyperpolarizing response to adenosine is nearly absent within 15 min of rupturing the membrane patch (Trussell and Jackson, 1987) . Since our recording protocol required at least 15 min of unitary EPSP recording prior to the administration of adenosine, and since we did not include GTP in our pipette filling solution, it is likely that all G-protein-mediated responses were virtually eliminated in the patched cells. Thus, the absence of postsynaptic effects of adenosine can most likely be explained by these factors.
The only pharmacological manipulation in the present study that had no effect upon the parameter m,, was the addition of the non-NMDA glutamate receptor antagonist DNQX, even though DNQX reduced average EPSP amplitudes substantially. This is in agreement with the findings of Malinow and Tsien (1990) where a similar glutamate. receptor antagonist (i.e., 6-cyano-7-nitroquinoxaline-2,3-dione
[CNQX]) was found to reduce average EPSP amplitudes without altering m,,. They did not, however, calculate q,,, which was clearly reduced by DNQX in the present study. Reductions in q,, by DNQX could reflect a presynaptic action, if it reduced vesicular neurotransmitter content (v), or a postsynaptic action to reduce glutamate sensitivity (Andreasen et al., 1988 (Andreasen et al., , 1989 Herreras et al., 1989) . This latter mechanism is consistent with the known ability of DNQX to bind to glutamate receptors. DNQX may thus provide a useful tool for comparison with other pharmacological manipulations suspected of acting postsynaptically to reduce synaptic efficacy.
The values of m, in the presence of DNQX were probably underestimated because of the prominent reduction of q,, by this antagonist. Thus, as quanta1 content decreases it becomes increasingly difficult to distinguish the diminished unitary responses from the background recording noise, and the smallest responses will be incorrectly labeled as "failures." This has been previously noted as a caveat of the method of failures when the baseline amplitude of q is small (Kom and Faber, 1991) , as is apparently the case at central synapses Foster and McNaughton, 1991; Larkman et al., 1991; Yamamoto et al., 199 1) . However, the prominent and consistent reduction in q,, by DNQX in the present study (approximately fourfold reduction; Figs. 3, 8) suggests that this parameter is sufficiently larger than the background recording noise in our preparation, and that the qualitative estimates of changes in this parameter are accurate, though the maximal effect of DNQX at the concentration used (1 PM) may have been underestimated.
The effects of DNQX on m,notwithstanding, the high degree of correspondence between mcv and mf demonstrates that these measures of synaptic efficacy arrive at similar estimates under most conditions. The finding that m,, usually overestimated mean quanta1 content as estimated by m, was not surprising since it has been noted that m,, overestimates mean quanta1 content when the probability of release (p) is large and the sample size is relatively small (de1 Castillo and Katz, 1954b; Martin, 1966; McLachlan, 1978; Foster and McNaughton, 1991; Yamamoto et al., 1991) .
In summary, the results of this investigation show that aden-osine, the selective adenosine Al agonist CHA, and the calcium channel blocker, cadmium, all reduce unitary EPSP amplitude via what appears to be a presynaptic mechanism. The glutamate receptor antagonist DNQX was also found to reduce unitary EPSP amplitudes, most likely by reducing transmitter sensitivity postsynaptically. The origin of the high degree of variability seen with unitary EPSP recording is not entirely clear. Although the most likely possibility is that it arises from variability in the number of quanta released at excitatory synapses, but other possibilities cannot be eliminated.
